v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Costs and expenses:    
Research and development $ 24,610 $ 24,087
Selling, general and administrative 11,103 10,959
Total costs and expenses 35,713 35,046
Loss from operations (35,713) (35,046)
Interest expense (7,933) (4,941)
Interest and other income 3,963 493
Net loss from continuing operations (39,683) (39,494)
Net income from discontinued operations, net of tax 5,982 6,483
Net loss $ (33,701) $ (33,011)
Basic net income (loss) per share continuing operations $ (0.63) $ (0.63)
Basic net income (loss) per share discontinued operations 0.09 0.10
Basic net income (loss) per share (0.54) (0.53)
Diluted net income (loss) per share continuing operations (0.63) (0.63)
Diluted net income (loss) per share discontinued operations 0.09 0.10
Diluted net income (loss) per share $ (0.54) $ (0.53)
Weighted-average shares used to compute basic net income (loss) per share (in shares) 62,828,765 62,724,775
Weighted-average shares used to compute diluted net income (loss) per share (in shares) 62,828,765 62,724,775